A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).

CompletedOBSERVATIONAL
Enrollment

589

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Non Small Cell Lung Cancer
Trial Locations (9)

Unknown

Research Site, Athens

Research Site, Crete

Research Site, Ioannina

Research Site, Kavala

Research Site, Larissa

Research Site, Pátrai

Research Site, Ptolemaida

Research Site, Thessaloniki

Research Site, Volos

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY